2. Academic Validation
  3. Novel Carbamate-Based o-aminobenzamide Derivatives as Potent Antigastric Carcinoma Agents via Disrupting NAD+ Salvage Synthesis

Novel Carbamate-Based o-aminobenzamide Derivatives as Potent Antigastric Carcinoma Agents via Disrupting NAD+ Salvage Synthesis

  • J Med Chem. 2025 Jun 12;68(11):10738-10756. doi: 10.1021/acs.jmedchem.4c02686.
Siyi Zhang 1,  Zhen Li 1,  Bo Li 1,  Zhiyi Li 1,  Huiqian Peng 1,  Lixian Shen 1 2,  Lejing Zhu 1,  Tong Mo 2,  Jialiang Peng 2,  Linsheng Zhuo 1,  Zhen Wang 1 2 3 4,  Weifan Jiang 1
Affiliations

Affiliations

  • 1 School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • 2 School of Basic Medicine, The First Affiliated Hospital, The Second Affiliated Hospital, MOE Key Lab of Rare Pediatric Diseases, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • 3 Qinghai Provincial Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, Qinghai, China.
  • 4 National Health Commission Key Laboratory of Birth Defect Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, Hunan, China.
PMID: 40448666 DOI: 10.1021/acs.jmedchem.4c02686
Abstract

Blocking NAD+ biosynthesis presents an appealing strategy for antitumor therapies. This study developed a series of o-aminobenzamide derivatives with substantial antitumor efficacy against gastric Cancer. Notably, compound 9a demonstrated exceptional antitumor activity against undifferentiated gastric Cancer HGC27 cells (IC50 = 0.049 μM), and significant inhibitory effects on cellular proliferation, self-renewal, invasion, and migration. Mechanistic investigations revealed that 9a could damage mitochondria, arrest the cell cycle, promote Apoptosis, and alter cellular metabolism. Furthermore, the rate-limiting enzyme NAMPT in the NAD+ salvage synthetic pathway was identified as a primary target of 9a. By inhibiting NAMPT, 9a reduced intracellular levels of NAD+ and ATP, while NMN, a natural product of NAMPT, counteracts its antimetabolic and cytotoxic effects. Overall, this study highlights 9a as a promising NAMPT Inhibitor with significant activity against undifferentiated gastric Cancer, laying the groundwork for developing novel antigastric Cancer agents through inhibiting NAD+ biosynthesis.

Figures
Products